Today: 20 June 2026

T-Mobile US (TMUS) Stock News Today, Dec. 22, 2025: Bernstein Holds Neutral as SoftBank Stake Sales and 2026 Buyback Plan Shape the Outlook

T-Mobile US (TMUS) Stock News Today, Dec. 22, 2025: Bernstein Holds Neutral as SoftBank Stake Sales and 2026 Buyback Plan Shape the Outlook

T-Mobile shares traded near $195 midday Monday, down slightly, as SoftBank sold $4.8 billion of its stake to help fund a $22.5 billion OpenAI commitment, Reuters reported. The company recently authorized a $14.6 billion shareholder return program and will pay a $1.02 quarterly dividend in March. Bernstein reiterated a Neutral rating with a $265 target. Analyst consensus remains “Buy” with an average target of $262.
22 December 2025
Warner Bros. Discovery (WBD) Stock Today: Paramount Sweetens $30 Offer With Larry Ellison Guarantee as Netflix Secures New Financing

Warner Bros. Discovery (WBD) Stock Today: Paramount Sweetens $30 Offer With Larry Ellison Guarantee as Netflix Secures New Financing

Warner Bros. Discovery shares rose Monday, closing near $28.70, after Paramount Skydance amended its $30-per-share hostile offer by adding a $40.4 billion personal guarantee from Larry Ellison. Netflix also revealed new financing moves for its agreed deal with WBD assets. Paramount extended its tender offer to January 21, 2026. Only 397,252 shares had been tendered as of December 19.
Lululemon Stock (LULU) Today: Elliott’s $1B Stake, CEO Shake-Up, New 2026 Expansion—and What Wall Street Forecasts Next (Dec. 22, 2025)

Lululemon Stock (LULU) Today: Elliott’s $1B Stake, CEO Shake-Up, New 2026 Expansion—and What Wall Street Forecasts Next (Dec. 22, 2025)

Lululemon shares traded near $211 on Dec. 22, up 0.8%, as investors reacted to CEO Calvin McDonald’s planned departure and news of Elliott Management’s $1 billion-plus stake. Meghan Frank and André Maestrini will serve as interim co-CEOs starting Jan. 31. The company also announced expansion into six new international markets in 2026.
Zenas BioPharma (ZBIO) Stock Hits a Record High on Dec. 22, 2025 as INDIGO Phase 3 Catalyst Nears — Latest News, Analyst Forecasts, and What’s Next

Zenas BioPharma (ZBIO) Stock Hits a Record High on Dec. 22, 2025 as INDIGO Phase 3 Catalyst Nears — Latest News, Analyst Forecasts, and What’s Next

Zenas BioPharma shares jumped about 14% to $41.23 on December 22, 2025, hitting a record high of $41.67 ahead of expected Phase 3 INDIGO trial results for obexelimab in IgG4-related disease. Citi and Wedbush both reiterated bullish ratings and price targets, citing the upcoming clinical data as a near-term catalyst.
22 December 2025
Polestar Automotive Holding (PSNY) Stock Jumps After New Funding: Today’s News, Forecasts, and Analyst Views (Dec. 22, 2025)

Polestar Automotive Holding (PSNY) Stock Jumps After New Funding: Today’s News, Forecasts, and Analyst Views (Dec. 22, 2025)

Polestar shares rose nearly 11% to $14.18 by midday Monday after announcing a $300 million equity investment from BBVA and Natixis and a $300 million debt-to-equity swap by Geely. The new shares will be priced at $19.34 each, with no single institution holding over 10%. The deal includes put options with Geely and is expected to close by Dec. 23, 2025.
Clearwater Analytics (CWAN) Stock Surges on $8.4 Billion Take-Private Deal: Price, Timeline, and What Analysts Are Saying (Dec. 22, 2025)

Clearwater Analytics (CWAN) Stock Surges on $8.4 Billion Take-Private Deal: Price, Timeline, and What Analysts Are Saying (Dec. 22, 2025)

Clearwater Analytics agreed to be acquired in an $8.4 billion all-cash deal, with shareholders set to receive $24.55 per share. The stock traded near $24.10 on December 22, below the offer price as investors weighed closing risk. Permira and Warburg Pincus, previous owners, are leading the buyout. The deal is expected to close in the first half of 2026, pending approvals.
Palo Alto Networks (PANW) Stock News Today: Google Cloud’s Near-$10 Billion Deal, AI-Security Momentum, and Analyst Forecasts (Dec. 22, 2025)

Palo Alto Networks (PANW) Stock News Today: Google Cloud’s Near-$10 Billion Deal, AI-Security Momentum, and Analyst Forecasts (Dec. 22, 2025)

Palo Alto Networks shares rose 1.5% to $189.65 on Dec. 22 after news of an expanded Google Cloud partnership, reportedly worth nearly $10 billion over several years. The deal includes integrating Palo Alto’s AI security tools with Google Cloud services and expanding firewall and SASE deployments. Analysts highlighted the partnership’s potential to drive recurring revenue but noted execution risks remain.
Rocket Lab (RKLB) Stock Surges on $816M Space Force Satellite Contract and Record 2025 Launches — What News and Forecasts Say on Dec. 22, 2025

Rocket Lab (RKLB) Stock Surges on $816M Space Force Satellite Contract and Record 2025 Launches — What News and Forecasts Say on Dec. 22, 2025

Rocket Lab shares climbed to new highs on Monday, Dec. 22, 2025, after the company announced an $816 million U.S. Space Development Agency contract to build 18 missile-tracking satellites. The stock gained mid-to-high single digits after an 18% rally Friday, fueled by the contract and a record year of Electron launches. The deal could reach $1 billion if Rocket Lab supplies subsystems to other contractors.
ServiceNow (NOW) Stock News, Forecasts and Analyst Outlook for Dec. 22, 2025: Armis Deal Chatter, Stock Split Fallout, and What Investors Watch Next

ServiceNow (NOW) Stock News, Forecasts and Analyst Outlook for Dec. 22, 2025: Armis Deal Chatter, Stock Split Fallout, and What Investors Watch Next

ServiceNow shares traded at $156.25 as of 17:00 UTC, up 0.6% after a 5-for-1 stock split took effect Dec. 18. The company completed its acquisition of Moveworks and is in reported talks to buy cybersecurity firm Armis for up to $7 billion. Shares fell over 11% on Dec. 15 after the Armis news surfaced. Analyst concerns focus on deal size and growth strategy.
22 December 2025
IonQ Stock (IONQ) Surges as Quantum Rebound Gathers Steam: Latest News, Analyst Forecasts, and Key Risks (Dec. 22, 2025)

IonQ Stock (IONQ) Surges as Quantum Rebound Gathers Steam: Latest News, Analyst Forecasts, and Key Risks (Dec. 22, 2025)

IonQ shares jumped 13.6% to $55.06 as of 17:20 UTC on Dec. 22, 2025, trading on heavy volume with no single news catalyst. The move followed new analyst coverage, including a Jefferies Buy rating and $100 target and a Wedbush Outperform at $60. Consensus targets remain widely dispersed, ranging from $30 to $100.
Goldman Sachs (GS) Stock Today, Dec. 22, 2025: Near Record High as M&A Tailwinds Meet Mixed 2026 Forecasts

Goldman Sachs (GS) Stock Today, Dec. 22, 2025: Near Record High as M&A Tailwinds Meet Mixed 2026 Forecasts

Goldman Sachs shares traded near $903 by midday Monday, within 2% of their 52-week high, after a year of strong gains driven by robust dealmaking and client activity. Reuters data shows Goldman led investment banking fees in EMEA in 2025 with a 6.8% share. The bank’s next earnings report is due January 15, 2026. Analyst price targets remain below current stock levels.
22 December 2025
Mastercard (MA) Stock News Today: Fiserv Agentic Commerce Partnership, UAE Virtual Cards, Dividend & Buyback Boost, and Wall Street Forecasts (Dec. 22, 2025)

Mastercard (MA) Stock News Today: Fiserv Agentic Commerce Partnership, UAE Virtual Cards, Dividend & Buyback Boost, and Wall Street Forecasts (Dec. 22, 2025)

Mastercard shares rose 0.8% to $576.90 on Dec. 22 after Fiserv expanded its partnership with the company to scale AI-driven “agentic commerce” for merchants. Mastercard also announced a new B2B payments launch with First Abu Dhabi Bank and a 14% dividend increase with a $14 billion buyback. Fee-related litigation and regulation remain in focus.
22 December 2025
AbbVie Stock News Today (Dec. 22, 2025): ABBV Holds Near $227 as Drug-Pricing Talks, Dividend Growth, and 2026 Catalysts Come Into Focus

AbbVie Stock News Today (Dec. 22, 2025): ABBV Holds Near $227 as Drug-Pricing Talks, Dividend Growth, and 2026 Catalysts Come Into Focus

AbbVie shares traded at $227.73 midday Monday, near recent highs, as the company remains one of three major drugmakers not signed onto the White House’s new “most-favored-nation” drug-pricing agreements announced December 19. Investors are watching for AbbVie’s next move on the policy front, while its core immunology drugs and dividend growth continue to anchor fundamentals.
Amgen Stock (AMGN) News Today: Trump Drug‑Price Deals, Analyst Forecasts, and What to Watch Next — Dec. 22, 2025

Amgen Stock (AMGN) News Today: Trump Drug‑Price Deals, Analyst Forecasts, and What to Watch Next — Dec. 22, 2025

Amgen shares rose to around $331 on December 22, 2025, after the White House announced drug-pricing deals with major drugmakers, including Amgen. The company will offer Aimovig and Amjevita at $299 per month through direct-to-patient sales. Analysts said the agreements may ease tariff and political risks but are unlikely to significantly affect pharma profits in the near term.

Stock Market Today

  • Fed's Warsh Cuts Guidance, Raising Market Volatility and Rates
    June 20, 2026, 9:25 AM EDT. Federal Reserve Chair Kevin Warsh reduced the Fed's interest-rate statement length, removing forward guidance that helped anchor market expectations. This communication rollback may increase volatility in stock and bond markets and push interest rates higher, though consumer impact could be modest. Treasury yields rose after the new approach, with the 10-year yield jumping to 4.49% and the S&P 500 dropping 1.2%. Warsh's strategy echoes former Chair Greenspan's less transparent style, which kept markets uncertain. The Fed plans task forces to review its communication and operations, signaling potential future reforms.

Latest articles

Pennsylvania gas prices near U.S. average ahead of July Fourth

Pennsylvania gas prices near U.S. average ahead of July Fourth

20 June 2026
Pennsylvania gasoline prices dropped 53.5 cents in a month to $4.109 a gallon, AAA data show, just before July Fourth travel; relief is driven by eased crude prices after a U.S.-Iran Strait of Hormuz deal, but state prices remain 74 cents above last year and 16 cents above the U.S. average, with supply risks and refinery bottlenecks threatening further declines.
JBS Plant Shutdowns Draw Attention to Beef Supply Limits Again

JBS Plant Shutdowns Draw Attention to Beef Supply Limits Again

20 June 2026
JBS USA will close its Souderton, PA beef plant and Memphis meat facility as tight cattle supplies and weak packer margins pressure the industry; the Souderton shutdown affects 1,485 workers and handles about 2,000 cattle daily, while JBS North American beef operations posted a $267 million negative adjusted EBITDA last quarter despite higher revenue.
Mortgage rates hit lowest in a month as Iran framework eases Treasury yields

Mortgage rates hit lowest in a month as Iran framework eases Treasury yields

20 June 2026
U.S. 30-year fixed mortgage rates fell to 6.47%, their lowest in over a month, after a U.S.-Iran framework deal eased Treasury yields, giving homebuyers modest relief as pending home sales rose 3.8% in May, but high borrowing costs and Fed inflation concerns continue to limit affordability and market momentum.
Go toTop